Viral-associated nonmelanoma skin cancers: A review

American Journal of Dermatopathology

Volumn 31, Issue 6, 2009, Pages 561-573

  Dubina, Meghan ^a   Goldenberg, Gary ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Malignancy; Nonmelanoma; Skin cancer; Viral; Virus

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CYTOKERATIN 20; DNA FRAGMENT; EPITHELIAL MEMBRANE ANTIGEN; KI 67 ANTIGEN; NEURON SPECIFIC ENOLASE; PROTEIN BCL 2; PROTEIN E6; PROTEIN E7; PROTEIN P53; THYROID TRANSCRIPTION FACTOR 1; VIRUS ANTIGEN; VIRUS DNA; VIRUS RNA; VIRUS T ANTIGEN;

ACTINIC KERATOSIS; AGE DISTRIBUTION; ANTIBODY TITER; BOWENOID PAPULOSIS; CANCER INCIDENCE; CANCER INFILTRATION; CHRONIC INFLAMMATION; DESMOSOME; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; EPIDERMODYSPLASIA VERRUCIFORMIS; EXTRAVASATION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENITAL SYSTEM; HETEROZYGOSITY LOSS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE DEFICIENCY; IMMUNOPEROXIDASE STAINING; IN SITU HYBRIDIZATION; KAPOSI SARCOMA; LETHALITY; MALIGNANT TRANSFORMATION; MEDICAL LITERATURE; MERKEL CELL TUMOR; METASTASIS; ONCOGENE; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; SEBORRHEIC KERATOSIS; SEX DIFFERENCE; SKIN BIOPSY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TONOFILAMENT; TUMOR BIOPSY; ULTRAVIOLET RADIATION; VERRUCOUS CARCINOMA; VIREMIA; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS LOAD; WART VIRUS;

HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS;

EID: 68949097283     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181a58234     Document Type: Review

References (195)

1. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007;4:462-469.
2. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55-F78. (Pubitemid 26335492)
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl JMed. 2003;348:518-527. (Pubitemid 36159887)
4. De Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology. 2004;324:17-27.
5. Asgari MM, Kiviat NB, Critchlow CW, et al. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol. 2008; 128:1409-1417.
6. Jablonska S, Orth G, Obalek S, et al. Cutaneous warts. Clinical, histologic, and virologic correlations. Clin Dermatol. 1985;3:71-82.
7. Nuovo GJ, Plaia TW, Belinsky SA, et al. In situ detection of the hypermethylation-induced inactivation of the p1 6 gene as an early event in oncogenesis. Proc Natl Acad Sci USA. 1999;96:12754-12759.
8. Segura S, Carrera C, Ferrando J, et al. Dermoscopy in epidermodysplasia verruciformis. Dermatol Surg. 2006;32:103-106.
9. De Oliveira WR, Festa Neto C, Rady PL, et al. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol. 2003; 17:394-398.
10. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol. 1984;83(1 Suppl): 18s-25s.
11. Lane JE, Bowman PH, Cohen DJ. Epidermodysplasia verruciformis. South MedJ. 2003;96:613-615.
12. Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol. 2002;138:649-654.
13. Ramoz N, Taieb A, Rueda LA, et al. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol. 2000;1 14:1148-1153.
14. Ramoz N, Rueda LA, Bouadjar B, et al. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32:579-581.
15. Orth G. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol. 2006;18:362-374.
16. Akgul B, Kose O, Safali M, et al. A distinct variant of epidermodysplasia verruciformis in a Turkish family lacking EVER1 and EVER2 mutations. J Dermatol Sci. 2007;46:214-216.
17. Gewirtzman A, Bartlett B, Tyring S. Epidermodysplasia verruciformis and human papilloma virus. Curr Opin Infect Dis. 2008;21:141-146.
18. Pfister H, Fuchs PG, Majewski S, et al. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res. 2003;295:273-279.
19. Weissenborn SJ, Nindl I, Purdie K, et al. Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol. 2005; 125:93-97.
20. Rehman I, Takata M, Wu YY, et al. Genetic change in actinic keratoses. Oncogene. 1996; 12:2483-2490.
21. Quinn AG, Sikkink S, Rees JL. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res. 1994;54:4756-4759.
22. Sterling JC. Human papillomaviruses and skin cancer. JClin Virol. 2005; 32(Suppl 1):S67-S71.
23. Forslund O, Lindelof B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "stripped" biopsies from the same tumors. J Invest Dermatol. 2004;123: 388-394.
24. Nuovo GJ, Ishag M. The histologic spectrum of epidermodysplasia verruciformis. Am J Surg Pathol. 2000;24:1400-1406.
25. Nuovo GJ. Cytopathology of the Lower Female Genital Tract: An Integrated Approach. Baltimore, MD: Williams & Wilkins; 1994.
26. Braun RP, Rabinovitz HS, Krischer J, et al. Dermoscopy of pigmented seborrheic keratosis: a morphological study. Arch Dermatol. 2002;138: 1556-1560.
27. Kawashima M. Epidermodysplasia verruciformis. J Dermatol. 1992;19: 707-709.
28. Sehgal VN, Luthra A, Bajaj P. Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing squamous cell carcinoma transformation. Int J Dermatol. 2002;41:500-503.
29. Astori G, Lavergne D, Benton C, et al. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol. 1998;110:752-755.
30. Boxman IL, Berkhout RJ, Mulder LH, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol. 1997;108:712-715.
31. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery. 1948;23: 670-678.
32. Koch BB, Trask DK, Hoffman HT, et al. National survey of head and neck verrucous carcinoma: patterns of presentation, care, and outcome. Cancer. 2001;92:1 10-120.
33. Schwartz RA. Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol. 1995;32:1-21; quiz 22-24.
34. Friedell HL, Rosenthal LM. The etiologic role of chewing tobacco in cancer of the mouth: report of eight cases treated with radiation. JAMA. 1941;116:2130-2135.
35. Shroyer KR, Greer RO, Fankhouser CA, et al. Detection of human papillomavirus DNA in oral verrucous carcinoma by polymerase chain reaction. Mod Pathol. 1993;6:669-672.
36. Fliss DM, Noble-Topham SE, McLachlin M, et al. Laryngeal verrucous carcinoma: A clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope. 1994;104: 146-152.
37. Lubbe J, Kormann A, Adams V, et al. HPV-11- and HPV-16-associated oral verrucous carcinoma. Dermatology. 1996; 192:217-221.
38. Jablonska S, Schwartz RA. Giant condyloma acuminatum of Buschke and Lowenstein. In: Demis DJ, ed. Clinical Dermatology. Vol 14-15. 18th ed. Philadelphia, PA: JB Lippincott; 1991:1-5.
39. Sang BC, Barbosa MS. Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins. Proc Natl Acad Sci USA. 1992;89:8063-8067.
40. Lehn H, Ernst TM, Sauer G. Transcription of episomal papillomavirus DNA in human condylomata acuminata and Buschke-Lowenstein tumours. J Gen Virol. 1984;65(pt 11):2003-2010.
41. Boshart M, zur Hausen H. Human papillomaviruses in Buschke-Lowenstein tumors: physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol. 1986;58:963-966.
42. Eisenberg E, Rosenberg B, Krutchkoff DJ. Verrucous carcinoma: a possible viral pathogenesis. Oral Surg Oral Med Oral Pathol. 1985 ;59: 52-57.
43. Adler-Storthz K, Newland JR, Tessin BA, et al. Human papillomavirus type 2 DNA in oral verrucous carcinoma. J Oral Pathol. 1986; 15: 472-475.
44. McCoy JM, Waldron CA. Verrucous carcinoma of the oral cavity. A review of forty-nine cases. Oral Surg Oral Med Oral Pathol. 1981;52: 623-629.
45. Rajendran R, Sugathan CK, Augustine J, et al. Ackerman's tumour (verrucous carcinoma) of the oral cavity: a histopathologic study of 426 cases. Singapore Dent J. 1989;14:48-53.
46. Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1 129-1136.
47. Pilotti S, Donghi R, D'Amato L, et al. HPV detection andp53 alteration in squamous cell verrucous malignancies of the lower genital tract. Diagn Mol Pathol. 1993;2:248-256.
48. Aydogan LB, Ozdemir S, Gumurdula D. Verrucous carcinoma of the temporal bone. Am J Otolaryngol. 2008;29:69-71.
49. Prioleau PG, Santa Cruz DJ, Meyer JS, et al. Verrucous carcinoma: a light and electron microscopic, autoradiographic, and immunofluo-rescence study. Cancer. 1980;45:2849-2857.
50. Buschke A. Condyloma acuminate. In: Neisser A, ed. Stereoscopischer Medicinischer Atlas. Kassel, Germany: T Fisher; 1896:61.
51. Klima M, Kurtis B, Jordan PH Jr. Verrucous carcinoma of skin. J Cutan Pathol. 1980;7:88-98.
52. Brownstein MH, Shapiro L. Verrucous carcinoma of skin: Epithelioma cuniculatum plantare. Cancer. 1976;38:1710-1716.
53. Pindborg JJ, Reichart PA, Smith CJ, et al. Histological Typing of Cancer and Precancer of the Oral Mucosa. 2nd ed. Berlin, Germany: Springer-Verlag; 1997.
54. Jacobson S, Shear M. Verrucous carcinoma of the mouth. J Oral Pathol. 1972;1:66-75.
55. Pereira MC, Oliveira DT, Landman G, et al. Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. JCan Dent Assoc. 2007; 73:339-344.
56. Barnes L, Eveson JW, Reichart P, et al. Oral cavity and oropharynx. In: Barnes L, Eveson JW, Reichart P, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon, France: International Agency for Research on Cancer Press; 2005:164-208.
57. Batsakis JG, Hybels R, Crissman JD, et al. The pathology of head and neck tumors: verrucous carcinoma, Part 15. Head Neck Surg. 1982;5: 29-38.
58. Niparko JK, Rubinstein MI, McClatchey KD. Invasive squamous cell carcinoma within verrucous carcinoma. J Otolaryngol. 1988;17:38-40.
59. Go JH, Oh YL, Ko YH. Hybrid verrucous squamous cell carcinoma of sinonasal tract: a case report. J Korean Med Sci. 1998;13:662-664.
60. Drachenberg CB, Blanchaert R, Ioffe OB, et al. Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover. Cancer Detect Prev. 1997;21:483-489.
61. Adegboyega PA, Boromound N, Freeman DH. Diagnostic utility of cell cycle and apoptosis regulatory proteins in verrucous squamous carcinoma. Appl Immunohistochem Mol Morphol. 2005;13:171-177.
62. de Belilovsky C, Lessana-Leibowitch M. [Bowen's disease and bowenoid papulosis: comparative clinical, viral, and disease progression aspects]. Contracept Fertil Sex. 1993;21:231-236.
63. Kessler GM, Ackerman AB. Nomenclature for very superficial squamous cell carcinoma of the skin and of the cervix: a critique in historical perspective. Am JDermatopathol. 2006;28:537-545.
64. Bonnekoh B, Mahrle G, Steigleder GK. [Transition to cutaneous squamous cell carcinoma in 2 patients with bowenoid papulomatosis]. Z Hautkr. 1987;62:773-776, 780-1774
65. Yoneta A, Yamashita T, Jin HY, et al. Development of squamous cell carcinoma by two high-risk human papillomaviruses (HPVs), a novel HPV-67 and HPV-31 from bowenoid papulosis. Br J Dermatol. 2000; 143:604-608.
66. Wade TR, Kopf AW, Ackerman AB. Bowenoid papulosis of the penis. Cancer. 1978;42:1890-1903.
67. Gissmann L, Wolnik L, Ikenberg H, et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA. 1983;80:560-563.
68. Gross G, Hagedorn M, Ikenberg H, et al. Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol. 1985;121:858-863.
69. Hama N, Ohtsuka T, Yamazaki S. Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin. J Dermatol. 2006;33:331-337.
70. Hama N, Ohtsuka T, Yamazaki S. Elevated amount of human papillomavirus 31 DNA in a squamous cell carcinoma developed from bowenoid papulosis. Dermatology. 2004;209:329-332.
71. Bocking A, Chatelain R, Salterberg A, et al. Bowenoid papulosis. Classification as a low-grade in situ carcinoma of the epidermis on the basis of histomorphologic and DNA ploidy studies. Anal Quant Cytol Histol. 1989;11:419-425.
72. Hagiwara M, Sasaki H, Matsuo K, et al. Loop-mediated isothermal amplification method for detection of human papillomavirus type 6, 11, 16, and 18. J Med Virol. 2007;79:605-615.
73. van Beurden M, ten Kate FW, Tjong AHSP, et al. Human papillomavirus DNA in multicentric vulvar intraepithelial neoplasia. Int J Gynecol Pathol. 1998;17:12-16.
74. Hildesheim A, Han CL, Brinton LA, et al. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol. 1997;90:748-754.
75. Richter ON, Petrow W, Wardelmann E, et al. Bowenoid papulosis of the vulva-immunotherapeutical approach with topical imiquimod. Arch Gynecol Obstet. 2003;268:333-336.
76. Obalek S, Jablonska S, Beaudenon S, et al. Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol. 1986;14:433-444.
77. Guillet GY, Braun L, Masse R, et al. Bowenoid papulosis. Demonstration of human papillomavirus (HPV) with anti-HPV immune serum. Arch Dermatol. 1984;120:514-516.
78. Lupulescu A, Mehregan AH, Rahbari H, et al. Venereal warts vs Bowen disease. A histologic and ultrastructural study of five cases. JAMA. 1977; 237:2520-2522.
79. Zelickson AS, Prawer SE. Bowenoid papulosis of the penis. Demonstration of intranuclear viral-like particles. Am J Dermatopathol. 1980;2:305-308.
80. Patterson JW, Kao GF, Graham JH, et al. Bowenoid papulosis. A clinicopathologic study with ultrastructural observations. Cancer. 1986;57:823-836.
81. Snijders PJ, Steenbergen RD, Heideman DA, et al. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006;208:152-164.
82. Bleeker MC, Heideman DA, Snijders PJ, et al. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27: 141-150.
83. Bleeker MC, Hogewoning CJ, Berkhof J, et al. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis. 2005 ;41:612-620.
84. Scheffner M, Romanczuk H, Munger K, et al. Functions of human papillomavirus proteins. Curr Top Microbiol Immunol. 1994; 186:83-99.
85. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.
86. Ranki A, Lassus J, Niemi KM. Relation of p53 tumor suppressor protein expression to human papillomavirus (HPV) DNA and to cellular atypia in male genital warts and in premalignant lesions. Acta Derm Venereol. 1995;75:180-186.
87. Yu DS, Kim G, Song HJ, et al. Morphometric assessment of nuclei in Bowen's disease and bowenoid papulosis. Skin Res Technol. 2004; 10:67-70.
88. Daley T, Birek C, Wysocki GP. Oral bowenoid lesions: differential diagnosis and pathogenetic insights. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:466-473.
89. Weedon D. Bowenoid papulosis. In: Weedon D, ed. Skin Pathology. 2nd ed. London, UK: Elsevier Science Ltd; 2002:705.
90. Gimeno E, Vilata JJ, Sanchez JL, et al. Bowenoid papulosis: clinical and histological study of eight cases. Genitourin Med. 1987;63: 109-113.
91. Johnson TM, Saluja A, Fader D, et al. Isolated extragenital bowenoid papulosis of the neck. J Am Acad Dermatol. 1999;41(pt 2): 867-870.
92. Ulbright TM, Stehman FB, Roth LM, et al. Bowenoid dysplasia of the vulva. Cancer. 1982;50:2910-2919.
93. Faber M, Hagedorn M. A light and electron microscopic study of bowenoid papulosis. Acta Derm Venereol. 1981 ;61:397-403.
94. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N EnglJ Med. 1992;327:1649-1662.
95. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N EnglJ Med. 2001;344:975-983.
96. Foote JA, Harris RB, Giuliano AR, et al. Predictors for cutaneous basal-and squamous-cell carcinoma among actinically damaged adults. Int J Cancer. 2001 ;95:7-1 1.
97. Marks R. An overview of skin cancers. Incidence and causation. Cancer. 1995;75(2 Suppl):607-612.
98. Barksdale SK, O'Connor N, Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am. 1997;6:625-638.
99. Haustein UF. [Epidermodysplasia verruciformis Lewandowsky-Lutz with multiple squamous epithelium and Bowen's carcinomas]. Dermatol Monatsschr. 1982;168:821-828.
100. Forslund O, Ly H, Reid C, et al. A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis. Br J Dermatol. 2003; 149:64-73.
101. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. JNatl Cancer Inst. 2006;98:389-395.
102. Struijk L, Bouwes Bavinck JN, Wanningen P, et al. Presence of human papillomavirus DNA in plucked eyebrow hairs is associated with a history of cutaneous squamous cell carcinoma. J Invest Dermatol. 2003;121:1531-1535.
103. Hall L, Struijk L, Neale RE, et al. Re: human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. JNatl Cancer Inst. 2006;98:1425-1426.
104. Iftner A, Klug SJ, Garbe C, et al. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of non-immunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res. 2003 ;63:7515-7519.
105. Biliris KA, Koumantakis E, Dokianakis DN, et al. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts. Cancer Lett 2000;161:83-88.
106. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49: 506-509.
107. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(pt 1):177-186.
108. Glover M, Cerio R, Corbett M, et al. Cutaneous squamoproliferative lesions in renal transplant recipients. Differentiation from lesions in immunocompetent patients. Am JDermatopathol. 1995;17:551-554.
109. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000;61:289-297.
110. Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol. 2006;54:290-300.
111. Tieben LM, Berkhout RJ, Smits HL, et al. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol. 1994;131:226-230.
112. Berkhout RJ, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 1995;33:690-695.
113. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst. 1996;88: 802-811.
114. de Villiers EM, Lavergne D, McLaren K, et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer. 1997;73:356-361.
115. Harwood CA, Surentheran T, Sasieni P, et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol. 2004;150: 949-957.
116. Forslund O, Iftner T, Andersson K, et al. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis. 2007;196:876-883.
117. Ho GY, Burk RD, Fleming I, et al. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer. 1994;56:788-792. (Pubitemid 24102741)
118. Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg. 2000;26: 521-530.
119. Broders AC. Practical points on the microscopic grading of carcinoma. N YState J Med. 1932;32:667-671.
120. Broders AC. Squamous-cell epithelioma of the skin: a study of 256 cases. Ann Surg. 1921 ;73:141-160.
121. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. Philadelphia, PA: JB Lippincott; 1990.
122. Weedon D. Squamous cell carcinoma. In: Weedon D, ed. Skin Pathology. 2nd ed. London, UK: Elsevier Science Ltd; 2002:772-775.
123. Stenback F, Makinen MJ, Jussila T, et al. The extracellular matrix in skin tumor development-a morphological study. J Cutan Pathol. 1999;26: 327-338.
124. Guenthner ST, Hurwitz RM, Buckel LJ, et al. Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation. J Am Acad Dermatol. 1999;41(pt 1): 443-448.
125. Mittelbronn MA, Mullins DL, Ramos-Caro FA, et al. Frequency of preexisting actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol. 1998;37:677-681.
126. Smolle J, Wolf P. Is favorable prognosis of squamous cell carcinoma of the skin due to efficient immune surveillance? Arch Dermatol. 1997; 133: 645-646.
127. Haeffner AC, Zepter K, Elmets CA, et al. Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma. Arch Dermatol. 1997;133:585-590.
128. Mohs FE, Lathrop TG. Modes of spread of cancer of skin. AMA Arch Derm Syphilol. 1952;66:427-439.
129. Bernstein SC, Lim KK, Brodland DG, et al. The many faces of squamous cell carcinoma. Dermatol Surg. 1996;22:243-254.
130. Subtil A, LeBoit PE. Lymphocytes + nerves = ? Am J Dermatopathol. 2000;22:362-364.
131. Kutzner H, Schwenzer G, Embacher G, et al. [Lymphoepithelioma-like carcinoma of the skin]. Hautarzt. 1991;42:575-579.
132. Wooldridge WE, Frerichs JB. Multiple adenoid squamous cell carcinoma. Arch Dermatol. 1971;104:202-206.
133. Pinkus GS, Kurtin PJ. Epithelial membrane antigen-a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies. Hum Pathol. 1985;16:929-940.
134. Wick MR, Kaye VN. The role of diagnostic immunohistochemistry in dermatology. Semin Dermatol. 1986;5:346-358.
135. Antman K, Chang Y. Kaposi's sarcoma. N EnglJ Med. 2000;342:1027-1038.
136. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl JMed. 1995;332:1181-1185.
137. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003;89:1221-1227.
138. Agraharkar ML, Cinclair RD, Kuo YF, et al. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int. 2004;66:383-389.
139. Morath C, Mueller M, Goldschmidt H, et al. Malignancy in renal transplantation. J Am Soc Nephrol. 2004;15:1582-1588.
140. Wimmer CD, Rentsch M, Crispin A, et al. The janus face of immunosuppression-de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int. 2007; 71:1271-1278.
141. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-1869.
142. Lu S, Tran TA, Jones DM, et al. Localized lymphedema (elephantiasis): a case series and review of the literature. J Cutan Pathol. 2009;36:1-20.
143. Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol. 2002;47:124-127.
144. Dictor M, Rambech E, Way D, et al. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol. 1996;148:2009-2016.
145. Ensoli B, Sgadari C, Barillari G, et al. Biology of Kaposi's sarcoma. EurJ Cancer. 2001 ;37:1251-1269.
146. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995;346: 799-802.
147. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 1996;10:175-180.
148. Noel JC, Hermans P, Andre J, et al. Herpesvirus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiology, clinical spectrum, and histologic features. Cancer. 1996;77:2132-2136.
149. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med. 1996;335:23 3-241.
150. Jacobson LP, Jenkins FJ, Springer G, et al. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis. 2000;181:1940-1949.
151. Renwick N, Halaby T, Weverling GJ, et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS. 1998;12:2481-2488.
152. Rezza G, Andreoni M, Dorrucci M, et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst. 1999;91:1468-1474.
153. de-The G, Bestetti G, van Beveren M, et al. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst. 1999;91:1888-1889.
154. Fiorelli V, Gendelman R, Sirianni MC, et al. gamma-interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood. 1998;91:956-967.
155. Sirianni MC, Vincenzi L, Fiorelli V, et al. gamma-interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood. 1998;91:968-976.
156. Dorfman RF. The histogenesis of Kaposi's sarcoma. Lymphology. 1984; 17:76-77.
157. Douglas JL, Gustin JK, Dezube B, et al. Kaposi's sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med. 2007;49: 119-138.
158. Gottlieb GJ, Ackerman AB. Kaposi's sarcoma: an extensively disseminated form in young homosexual men. Hum Pathol. 1982;13: 882-892.
159. Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol. 1987;14(Suppl 3): 13-18.
160. MacPhail LA, Dekker NP, Regezi JA. Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma. J Cutan Pathol. 1996;23: 464-472.
161. Regezi JA, MacPhail LA, Daniels TE, et al. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. Am J Pathol. 1993;143: 240-249.
162. Uccini S, Ruco LP, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol. 1994;173: 23-31.
163. Dorfman RF. Kaposi's sarcoma. With special reference to its manifestations in infants and children and to the concepts of Arthur Purdy Stout. Am JSurg Pathol. 1986;10(Suppl 1):68-77.
164. Murray JF, Lothe F. The histopathology of Kaposi's sarcoma. Acta Unio Int Contra Cancrum. 1962;18:413-428.
165. Kao GF, Johnson FB, Sulica VI. The nature of hyaline (eosinophilic) globules and vascular slits of Kaposi's sarcoma. Am J Dermatopathol. 1990;12:256-267.
166. Waldo E. Subtle clues to diagnosis by electron microscopy. Kaposi's sarcoma. Am J Dermatopathol. 1979;1:177-180.
167. Chor PJ, Santa Cruz DJ. Kaposi's sarcoma. A clinicopathologic review and differential diagnosis. J Cutan Pathol. 1992;19:6-20.
168. Eng W, Cockerell CJ. Histological features of kaposi sarcoma in a patient receiving highly active antiviral therapy. Am J Dermatopathol. 2004;26: 127-132.
169. Robin YM, Guillou L, Michels JJ, et al. Human herpesvirus 8 immunostaining: a sensitive and specific method for diagnosing Kaposi sarcoma in paraffin-embedded sections. Am J Clin Pathol. 2004; 121: 330-334.
170. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096-1100.
171. Garneski KM, DeCaprio JA, Nghiem P. Does a new polyomavirus contribute to Merkel cell carcinoma? Genome Biol. 2008;9:228.
172. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation. 1999;68:1717-1721.
173. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58:375-381.
174. Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection. Lancet. 2002;359:497-498.
175. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999;8: 153-158.
176. zur Hausen H. Novel human polyomaviruses-re-emergence of a well known virus family as possible human carcinogens. Int J Cancer. 2008; 123:247-250.
177. Kassem A, Schopflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 2008;68:5009-5013.
178. Smith KJ, Skelton HG III, Holland TT, et al. Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component. Am J Dermatopathol. 1993;15:528-533.
179. Weedon D. Merkel cell (neuroendocrine) carcinoma. In: Weedon D, ed. Skin Pathology. 2nded. London, UK: Elsevier Science Ltd; 2002:989-991.
180. Warner TF, Uno H, Hafez GR, et al. Merkel cells and Merkel cell tumors. Ultrastructure, immunocytochemistry and review of the literature. Cancer. 1983 ;52:23 8-245.
181. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105: 107-110.
182. Leong AS, Phillips GE, Pieterse AS, et al. Criteria for the diagnosis of primary endocrine carcinoma of the skin (Merkel cell carcinoma). A histological, immunohistochemical and ultrastructural study of 13 cases. Pathology. 1986;18:393-399.
183. Schmidt U, Muller U, Metz KA, et al. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung. Am J Dermatopathol. 1998;20: 346-351.
184. Smith DF, Messina JL, Perrott R, et al. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control. 2000;7:72-83.
185. Frigerio B, Capella C, Eusebi V, et al. Merkel cell carcinoma of the skin: the structure and origin of normal Merkel cells. Histopathology. 1983;7: 229-249.
186. Argenyi ZB. Primary neuroendocrine carcinoma of the skin. In: Barnhill RL, Crowson AN, eds. Textbook of Dermatopathology. 2nd ed. New York, NY: McGraw-Hill; 2004:906-907.
187. Isimbaldi G, Sironi M, Taccagni G, et al. Tripartite differentiation (squamous, glandular, and melanocytic) of a primary cutaneous neuroendocrine carcinoma. An immunocytochemical and ultrastructural study. Am J Dermatopathol. 1993; 15:260-264.
188. Cerroni L, Kerl H. Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous- and basal-cell carcinoma. Am J Dermatopathol. 1997;19:610-613.
189. Kossard S, Wittal R, Killingsworth M. Merkel cell carcinoma with a desmoplastic portion. Am J Dermatopathol. 1995; 17: 517-522.
190. Zak FG, Lawson W, Statsinger AL, et al. Intracellular amyloid in trabecular (Merkel cell) carcinoma of skin: ultrastructural study. Mt Sinai JMed. 1982;49:46-54.
191. Sibley RK, Rosai J, Foucar E, et al. Neuroendocrine (Merkel cell) carcinoma of the skin. A histologic and ultrastructural study of two cases. Am J Surg Pathol. 1980;4:211-221.
192. Layfield L, Ulich T, Liao S, et al. Neuroendocrine carcinoma of the skin: an immunohistochemical study of tumor markers and neuroendocrine products. J Cutan Pathol. 1986;13:268-273.
193. Hall PA, d'Ardenne AJ, Butler MG, et al. Cytokeratin and laminin immunostaining in the diagnosis of cutaneous neuro-endocrine (Merkel cell) tumours. Histopathology. 1986;10:1 179-1190.
194. Hanly AJ, Elgart GW, Jorda M, et al. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol. 2000;27:1 18-120.
195. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol. 2004;5: 593-599.